Gotham Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-11,865
Closed -$58K 1244
2022
Q2
$58K Sell
11,865
-22,663
-66% -$140K ﹤0.01% 1096
2022
Q1
$263K Sell
34,528
-1,389
-4% -$10.8K 0.01% 989
2021
Q4
$332K Buy
35,917
+15,373
+75% +$163K 0.01% 921
2021
Q3
$293K Buy
+20,544
New +$319K 0.01% 843

Other funds holding ORGO

Gotham Asset Management's ORGO Position: Q3 2022 in Review

Gotham Asset Management sold out of Organogenesis Holdings (ORGO) in Q3 2022, closing a stake of 11,865 shares — an estimated $58K sold.

Gotham Asset Management first reported a position in ORGO in Q3 2021 and held it in 4 quarters. The position peaked at $332K in Q4 2021. 154 funds tracked by Wall St. Rank hold ORGO as of Q3 2022.

  • Gotham Asset Management reported no remaining Organogenesis Holdings position as of Q3 2022 after selling out during the quarter.
  • Gotham Asset Management sold 11,865 Organogenesis Holdings shares in Q3 2022, an estimated $58K.
  • Gotham Asset Management first reported a position in Organogenesis Holdings in Q3 2021 and held it in 4 quarters.
  • Gotham Asset Management's Organogenesis Holdings position peaked at $332K in Q4 2021.
  • 154 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2022.

Based on Gotham Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.